Application of tuna peptides in regulating intestinal flora and improving depressive-like behavior

Tuna peptide prepared by enzymatic lysis significantly improves depression-like behavior in mouse models, reduces inflammatory factors and LPS levels, restores intestinal 5-HT content, regulates intestinal flora, and solves the ineffective treatment of depression in the prior art and The problem of long-term drug side effects provides a new direction for green antidepressant treatment.

CN114366801BActive Publication Date: 2024-12-03GUANGDONG OCEAN UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111517265.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-13
Publication Date
2024-12-03
Estimated Expiration
2041-12-13

AI Technical Summary

Technical Problem

In the prior art, depression treatment is ineffective for about 1/3 of the patients, and long-term monoamine drugs have adverse effects on the body, lacking natural antidepressant functional active ingredients that are green and healthy, without side effects, and tuna peptides are used in the treatment of depression. No research has been reported on the application.

Method used

Tuna peptide was prepared by enzymatic method, and the intervention was performed using a chronic unpredictable mild stress mouse model. Combined with behavioral, inflammatory factors, LPS, 5-HT and intestinal flora indicators, the intervention effect of tuna peptide on depression-like behavior was investigated. The intervention pathway is initially analyzed based on the intestinal-brain axis.

Benefits of technology

Tuna peptide significantly improves depression-like behavior in mice, reduces serum inflammatory factors and LPS levels, restores the hippocampus and intestinal 5-HT content, improves the richness of intestinal flora, regulates the structure of intestinal flora, and protects the intestinal barrier. Better than fish oil group effect.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114366801B_ABST
    Figure CN114366801B_ABST
Patent Text Reader

Abstract

The present invention belongs to the technical field of functional application of seafood, and discloses the application of tuna peptide in regulating intestinal flora and improving depressive-like behavior. The study found that after the intervention of tuna peptide, the significantly elevated inflammatory factors and LPS levels in the serum of model mice were restored, and the significantly reduced 5-HT content in the hippocampus and intestinal tissue and significantly elevated 5-HT content in feces were also restored to the level of the blank control group; the intestinal flora Bacteroidota / Firmicutes The (B / F) ratio increased from 1.58 in the model group to 6.61, basically returning to the level of the blank group; Muribaculaceae Abundance and increase Bacteroides , Alistipes The abundance of tuna peptides was restored to the level of the blank group. Conclusion: Tuna peptides may improve the depressive-like behavior of mice induced by chronic stress by regulating intestinal flora, inflammation and intestinal 5-HT levels.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of functional application of seafood, and more specifically, relates to the application of tuna peptides in regulating intestinal flora and improving depressive-like behavior. Background Art

[0002] Depression is a depressive disorder characterized by a significant and persistent low mood. Clinically, it can be seen that the patient has a low mood, stupor, and lack of desire to live. During the onset of the disease, the level of 5-hydroxytryptamine (5-HT) in the patient's serum is significantly reduced, accompanied by brain inflammation. According to the 2017 WHO survey report, the number of depression patients in the world has increased by more than 18% in the past 10 years, and has exceeded 300 million by 2015. It is estimated that by 2030, depression will become one of the primary factors in the burden of human disease.

[0003] At present, the treatment of depression is mainly based on monoamine neurotransmitter drugs, but the first-line clinical treatment still has no therapeutic effect on about 1 / 3 of patients. Therefore, further research is needed on its potential pathogenesis and efficient prevention and treatment methods. Due to the long course of depression, long-term use of monoamine drugs will have more adverse effects on the body and produce drug resistance. Therefore, green, healthy, and side-effect-free food-derived natural antidepressant functional active ingredients have become a new hotspot in current research. Marine active peptides have received widespread attention due to their biomedical value. Tuna peptides, as a marine-derived polypeptide, have made certain progress in disease treatment and bioactivity research, but there are currently no reports on the application of tuna peptides in the treatment of depression.

[0004] It is generally believed that the pathogenesis of depression is mainly based on the neurotrophic factor hypothesis and the monoamine neurotransmitter hypothesis, namely, abnormal expression of brain-derived neurotrophic factor, autophagy of astrocytes in the hippocampus, and decreased secretion and increased reuptake of 5-hydroxytryptamine (5-HT) in the hippocampus. However, these hypotheses cannot fully explain all the phenomena of depression. In recent years, the scientific community has found that inflammation is one of the pathways for depression, which can explain the various endocrine abnormalities caused by depression. Therefore, in recent years, the inflammation hypothesis has gradually attracted the attention of scientific researchers. Inflammation is a pathological state of nonspecific, systemic, and persistent pro-inflammatory or anti-inflammatory response imbalance caused by an imbalance of the immune regulation system induced by chronic stress, drugs, and improper diet. It is mainly manifested by a significant increase in the levels of inflammatory markers such as TNF-α, IL-1, and IL-6 in the blood circulation. More and more studies have found that imbalance of the intestinal flora-mucosal barrier is an important driving force for inducing systemic inflammation and depression. Studies have reported that under chronic stress conditions, the intestinal flora of mice will be disturbed, intestinal permeability will increase significantly, and the LPS level in the blood will rise, inducing a significant increase in pro-inflammatory factors, forming a low-grade inflammation of the body system. Inflammatory factors in the blood can cross the blood-brain barrier to activate or participate in brain inflammatory reactions, affecting the release of neurotransmitters such as 5-HT in the brain, and causing depression. However, the role of tuna peptides in this pathway has yet to be explored. Summary of the invention

[0005] The technical problem to be solved by the present invention is to overcome the above-mentioned problems existing in the prior art. Firstly, the application of tuna peptide in preparing a functional product for improving depressive-like behavior is provided.

[0006] The purpose of the present invention is achieved through the following technical solutions:

[0007] Application of tuna peptides in the preparation of functional products for improving depressive-like behaviors.

[0008] In this study, tuna peptides were prepared by enzymatic hydrolysis of tuna meat. A mouse depression model was established using chronic unpredictable mild stress (CUMS, hereinafter referred to as chronic stress), and intervention was carried out by gavage of tuna peptides. Combined with the determination of behavioral, inflammatory factors, LPS, 5-HT and intestinal flora indicators, the intervention effect of tuna peptides on depressive-like behaviors was investigated. The intervention pathway of tuna peptides was preliminarily analyzed based on the gut-brain axis, providing an experimental basis for the development of tuna peptide antidepressant products.

[0009] The results showed that compared with the model group, the depressive behavior of mice in the tuna peptide group was significantly improved and better than that in the fish oil group. The study also found that after tuna peptide intervention, the significantly elevated levels of inflammatory factors and LPS in the serum of the model mice were restored, and the significantly reduced 5-HT content in the hippocampus and intestinal tissues and significantly increased 5-HT content in the feces were restored to the level of the blank control group; the significantly decreased intestinal flora richness was significantly improved; the intestinal flora Bacteroidota / Firmicutes The (B / F) ratio increased from 1.58 in the model group to 6.61, basically returning to the level of the blank group; the model group significantly decreased Muribaculaceae The abundance and significant increase Bacteroides , Alistipes The abundance of tuna peptides was restored to the level of the blank group. Conclusion: Tuna peptides may improve the depressive-like behavior of mice by regulating intestinal flora, inflammation and intestinal 5-HT levels.

[0010] Preferably, the tuna peptide can reduce the level of inflammatory factors in serum.

[0011] More preferably, the inflammatory factor is selected from TNF-α, IL-1β, IL-2, IL-6 and LPS.

[0012] Preferably, tuna peptides are able to modulate the composition and structure of intestinal flora.

[0013] More preferably, tuna peptides are used to increase Muribaculaceae and reduce Bacteroid e and Alistipes Abundance, protect the intestinal barrier, and reduce the entry of inflammatory factors into the blood.

[0014] Preferably, the tuna peptide can reduce the content of 5-HT in feces.

[0015] Preferably, the tuna peptide is prepared by enzymatic hydrolysis.

[0016] More preferably, the preparation method of tuna peptide is as follows: tuna meat homogenate is freeze-dried into powder, tuna powder and distilled water are mixed in a volume ratio of 1:5 for homogenization, pH is adjusted to 10.5, and the enzyme amount is 10000 U·g -1 , enzymolyze in a constant temperature water bath at 55 ℃ for 8 h, stir continuously during the enzymolysis process, inactivate the enzyme in a water bath at 95 ℃ for 30 min, cool to room temperature, centrifuge at 4000 r / min for 20 min, take the supernatant for vacuum freeze-drying, and obtain tuna peptide powder.

[0017] More preferably, the dosage of the tuna peptide is 1.8 g / (Kg mb•d).

[0018] Compared with the prior art, the present invention has the following beneficial effects:

[0019] The present invention investigated the intervention effect of tuna peptides on the depressive-like behavior of mice, and preliminarily analyzed the intervention pathway of tuna peptides based on the gut-brain axis, providing a theoretical basis for the development of a new generation of therapeutic agents. The results of the study showed that compared with the model group, the depressive-like behavior of mice in the tuna peptide group was significantly improved and was better than that in the fish oil group. The study also found that after the intervention of tuna peptides, the significantly elevated levels of inflammatory factors and LPS in the serum of model mice were restored, and the significantly reduced 5-HT content in the hippocampus and intestinal tissues and significantly increased 5-HT content in the feces also returned to the level of the blank control group; the significantly decreased richness of the intestinal flora was significantly improved; the intestinal flora Bacteroidota / Firmicutes The (B / F) ratio increased from 1.58 in the model group to 6.61, basically returning to the level of the blank group; the model group significantly decreased Muribaculaceae The abundance and significant increase Bacteroides , Alistipes The abundance of tuna peptides was restored to the level of the blank group. Conclusion: Tuna peptides may improve the depressive-like behavior of mice induced by chronic stress by regulating intestinal flora, inflammation and intestinal 5-HT levels. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 The improvement effect of tuna peptide on the behavior of chronic stressed mice; Figure A is the sugar water consumption rate, Figure B is the tail suspension test, Figure C is the open field test, and Figure D is the elevated plus maze test; * indicates a significant difference between the two groups (P<0.05);

[0021] Figure 2 The improvement effect of tuna peptide on the inflammation level of chronic stress mice; Figure A is TNF-α, Figure B is IL-1β, Figure C is IL-2, and Figure D is IL-6; * indicates that there is a significant difference between the two groups (P<0.05);

[0022] Figure 3 The effect of tuna peptide on 5-HT content in the hippocampus, intestinal tissue and intestinal flora of chronic stressed mice; Figure A shows 5-HT in the hippocampus, Figure B shows intestinal tissue; Figure C shows 5-HT in the intestinal flora; * indicates significant difference between the two groups (P<0.05);

[0023] Figure 4 The effect of tuna peptide on serum LPS content in chronic stress mice; * indicates significant difference between the two groups (P<0.05);

[0024] Figure 5 The effect of tuna peptide on intestinal flora OUT in chronic stressed mice; the upper bar graph is the total number of OUT, the left bar graph is the original number of OUT in each group, and the points and lines below represent the total OUT types;

[0025] Figure 6 The effect of tuna peptides on the Alpha diversity of intestinal flora in chronic stressed mice, where Figure A is Chaol, Figure B is Ace, Figure C is Shannon, and Figure D is Simpson; * indicates a significant difference between the two groups (P<0.05);

[0026] Figure 7 The effect of tuna peptide on the Beta diversity of intestinal flora in chronic stressed mice, where Figure A is a three-dimensional PcoA map and Figure B is a two-dimensional PcoA map;

[0027] Figure 8 The effect of tuna peptide on the species composition of the intestinal flora at the phylum and genus levels in chronic stress mice; Figure A shows the species composition at the phylum level, and Figure B shows the species composition at the genus level;

[0028] Figure 9 This is a cluster heat map of the correlation between 5-HT, inflammatory factors, behavior, and intestinal flora. The intestinal flora is the top ten changing genera at the genus level. * represents a significant difference between the two groups (P<0.05), and ** represents a very significant difference between the two groups (P<0.05). DETAILED DESCRIPTION

[0029] The specific embodiments of the present invention are further described below. It should be noted that the description of these embodiments is used to help understand the present invention, but does not constitute a limitation of the present invention. In addition, the technical features involved in each embodiment of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0030] Unless otherwise specified, the test methods used in the following embodiments and experimental examples are all conventional methods; the materials, reagents, etc. used, unless otherwise specified, are reagents and materials that can be obtained from commercial channels; the equipment used, unless otherwise specified, are all conventional experimental equipment. Example

[0031] 1. Experimental Animals

[0032] 24 healthy specific pathogen-free (SPF) male C57BL / 6 mice were obtained from Changsha Tianqin Biotechnology Co., Ltd., 3 weeks old, with an average body weight of 10±0.5 g, and the experimental animal license number was SCXK (Beijing) 2016-0002. The experimental mice were housed in the SPF animal room of the School of Food Science and Technology of Guangdong Ocean University (license number: SYKX (Guangdong) 2014-0053), with a temperature of 22±1℃, day and night alternation (12 h light + 12 h dark), free access to food and water, and the feeding and operation of experimental animals were carried out in accordance with the SPF animal laboratory management regulations of Guangdong Ocean University.

[0033] 2. Preparation of tuna peptide

[0034] The method of Lü Le et al. was used with some improvements. Tuna meat homogenate was freeze-dried into powder, tuna powder and distilled water were mixed at a volume ratio of 1:5 for homogenization, pH was adjusted to 10.5, and the enzyme amount was 10000 U·g -1 , enzymolyze in a constant temperature water bath at 55 ℃ for 8 h, stir continuously during the enzymolysis process, inactivate the enzyme in a water bath at 95 ℃ for 30 min, cool to room temperature, centrifuge at 4000 r / min for 20 min, take the supernatant for vacuum freeze-drying, and obtain tuna peptide powder.

[0035] 3. Animal grouping

[0036] Twenty-four 3-week-old healthy SPF male C57BL / 6 mice were randomly divided into a blank control group, a model group, a fish oil-positive control group, and a tuna peptide group, with 6 mice in each group. The blank group and the model group were gavaged with an equal amount of distilled water, and the positive control group was gavaged with 0.72 g / (Kg m b ·d), the intragastric dose of tuna peptide group was 0.8 g / (Kg m b ·d). Starting from the 15th day of stress, mice were gavaged once a day for 30 days.

[0037] 4. Establishment of depression model

[0038] This experiment used chronic unpredictable mild stress to establish a depression animal model. Stress selection: ① noise for 30 minutes, ② tilting the mouse cage for 24 hours, ③ continuous light for 24 hours, ④ 12 ℃ cold water bath for 6 minutes, ⑤ suspension for 30 minutes, ⑥ fasting for 24 hours, ⑦ water deprivation for 24 hours, 1-2 types of stress were given every day, and the same stimulus was not given for three consecutive days for 44 days.

[0039] 5. Mouse sample collection

[0040] Behavior was measured after 44 days. Then, the feces of mice were collected by induced defecation. 2 g of feces were collected from each mouse, and immediately divided into sterile 1.5 mL centrifuge tubes, sealed and placed in a -80 ℃ refrigerator. Blood was obtained by eye sampling, placed in a 4 ℃ refrigerator for 30 min, and then centrifuged at 8000 r / min and 4 ℃ for 20 min to obtain the supernatant to obtain mouse serum. The mice were killed by cervical dislocation, and 1 cm of intestinal tissue was obtained from the mouse (5 cm from the colon end to the small intestine).

[0041] 6. Index detection method

[0042] Amino acid determination: After obtaining tuna peptides, the amino acid composition of the sample was determined using an amino acid analyzer in accordance with GB 5009.124-2016 “National Food Safety Standard Determination of Amino Acids in Foods”.

[0043] Behavioral methods (N=6): Referring to the behavioral methods of field research, the sugar water preference test, tail suspension test, open field test and elevated plus maze test were measured.

[0044] Inflammatory factor determination (N=6): ELISA kits were used to determine TNF-α, IL-1β, IL-2 and IL-6 in mouse serum.

[0045] Determination of HT-5 content in mouse tissue (N=6): refer to the method of determining neurotransmitters by Zhang Lei et al., and slightly modify the instrument conditions;

[0046] Chromatographic column: amino column (4.5 mm × 150 mm, 5 μm), column temperature: 35 °C, mobile phase: acetonitrile: 0.1% formic acid aqueous solution = 2:8, flow rate: 0.3 mL / min;

[0047] Injector temperature: 4 °C, mass spectrometer detector ionization was performed by electrospray ionization, and scanning was performed in positive ion multiple reaction monitoring (MRM) mode. The ion source and other related parameters were as follows: spray voltage 4500 V, heating temperature 450 °C, Gas1 50 Psi, Gas2 50 Psi.

[0048] LPS determination (N=6): The LPS content in mouse serum was determined using a horseshoe crab kit.

[0049] Microbial diversity sequencing was used to determine the intestinal flora of mice (N=6): PCR amplification of the 16s target region was performed using DNA that passed the quality inspection, and universal primers were designed. After amplification, electrophoresis was performed and finally, the qualified libraries were subjected to high-throughput sequencing using the Illumina NovaSeq platform.

[0050] Intestinal flora data analysis: The raw data was screened to obtain the effective data Clean data, and then the Reads were spliced ​​into Tags through Overlap. The Tags were clustered into OUT / ASV at a specific similarity, and various diversity analyses and sequencing depth tests were performed based on the clustering results. Then, classification annotations were performed by comparing with the database. The Kruskal method of the R stats package was used to compare the differences in phylum, class, order, family, and genus at each classification level between samples or groups.

[0051] Statistical analysis method: This experiment used JMP Pro 14 software for significance analysis, and Lianchuan Bio Cloud Platform and Origin 2021 software for drawing.

[0052] As shown in Table 1, tuna peptides are rich in functional amino acids such as glycine (Gly), glutamic acid (Glu), and arginine (Arg).

[0053] Table 1 Amino acid composition of tuna peptides

[0054] Amino acid Mass fraction / % Amino acid Mass fraction / % Asp 3.87% Ile 0.95% Thr 1.62% Leu 2.02% Ser 2.21% Tyr 0.06% Glu 7.10% Phe 1.17% Gly 15.54% Lys 2.49% Ala 6.82% Pro 8.21% Cys 0.07% His 0.59% Val 1.59% Arg 4.87% Met 0.24% Total amino acid 59.42%

[0055] Chronic stress led to a decrease in the sugar water consumption rate of mice, but there was no significant difference; the 4-minute immobility time after the tail suspension test increased, the time to enter the middle area of ​​the open field test decreased, and the time to explore the open arm of the elevated plus maze decreased, and there were significant differences compared with the blank group (P < 0.05). After the intervention of tuna peptides, the sugar water consumption rate increased, but there was no significant difference; the 4-minute immobility time after the tail suspension test decreased, the time to enter the middle area of ​​the open field test increased, and the time to explore the open arm of the elevated plus maze increased, all of which were significantly different from the model group (P < 0.05), and there was no significant difference from the blank group, and the effect was better than the fish oil positive control group. This shows that after the intervention of tuna peptides, the time of despair in mice was significantly reduced, the desire to explore open space and high-altitude environment was significantly increased, and the behavioral performance returned to normal levels, that is, the depressive-like behavior of mice was significantly improved.

[0056] Chronic stress leads to an increase in the level of inflammation in mice, which is manifested by a significant increase in TNF-α, IL-1β, IL-2, and IL-6. After intervention with tuna peptides, all inflammatory factors decreased significantly and returned to the level of the blank group, among which IL-1β, IL-2, and IL-6 were better than the fish oil positive control group. This shows that tuna peptides can reduce inflammation levels.

[0057] Chronic stress caused a significant decrease in the 5-HT content in the hippocampus and intestinal tissue of mice. After intervention with tuna peptides, the 5-HT content in the hippocampus and intestinal tissue increased significantly, with no significant difference compared with the blank group.

[0058] Chronic stress also led to a significant increase in the 5-HT content in the intestinal flora of the model group. After tuna peptide intervention, the 5-HT content in the intestinal flora decreased significantly.

[0059] Compared with the blank group, chronic stress caused a significant increase in the LPS content in the mouse serum. After intervention with tuna peptides, the LPS content in the serum decreased significantly, with no significant difference compared with the blank group. This shows that chronic stress can cause intestinal LPS to enter the blood, and tuna peptides can significantly reduce the entry of LPS into the blood circulation.

[0060] (1) OUT Upset diagram

[0061] By comparing the number of common OUTs, it can be seen that compared with the blank group, the model group has 423 common OUTs and 263 unique OUTs, while the tuna peptide group has 488 common OUTs and 225 unique OUTs. This shows that after chronic stress, the intestinal flora species in the model group are quite different from those in the blank group, and after the intervention of tuna peptides, the intestinal flora species have returned to a level close to that of the blank group.

[0062] (2) Alpha diversity analysis

[0063] Alpha diversity analysis is an analysis method for the richness and diversity of intestinal flora. Chao1 and Ace index are analysis indicators of richness, and Shannon and Simpson index are analysis indicators of diversity.

[0064] After chronic stress, Chao1 and Ace indexes decreased significantly, and the richness of intestinal flora decreased. After tuna peptide intervention, the richness of intestinal flora increased significantly; Shannon and Simpson increased significantly, and the diversity of intestinal flora changed significantly. After tuna peptide intervention, the diversity of intestinal flora returned to the level of the blank group. From the Alpha diversity, it can be seen that chronic stress can cause the number of intestinal flora to decrease, and after tuna peptide intervention, the intestinal flora returned to normal levels.

[0065] (3) Beta diversity analysis

[0066] It can be seen from the three-dimensional PCoA graph of the intestinal flora and the two-dimensional PCoA graph formed by the variance decomposition based on the three-dimensional graph coordinate axes PC1 and PC2 that after chronic stress, the intestinal flora of the model group mice in the PCoA three-dimensional spatial distribution and the two-dimensional coordinate graph are far away from the blank group, and there is no overlapping part in the confidence ellipse of the two-dimensional coordinate graph; after tuna peptide intervention, the coordinates of the tuna peptide group and the blank group are similar in three-dimensional space, and the two-dimensional confidence ellipses almost completely overlap, which indicates that tuna peptide can effectively improve the intestinal flora disorder caused by chronic stress and restore it to normal levels.

[0067] (4) Species composition analysis

[0068] The top ten phyla and genera in terms of content were taken for plotting at the phylum and genus levels, and the genera after the top ten at the genus level were represented as Other.

[0069] From the bar graph of the gate level, we can see that the model group Bacteroidota The proportion is 59.9%. Firmicutes The proportion is 37.8%. Bacteroidota / Firmicutes (B / F) = 1.58. BacteroidotaThe proportion of tuna peptide group was 82.4%, the proportion of Firmicutes was 15.3%, and the B / F was 5.38. Bacteroidota The proportion is 85.3%. Firmicutes The proportion was 12.9%, B / F=6.61, and the sum of the proportions of the two bacterial phyla in each group exceeded 95%. This shows that tuna peptides can significantly improve the changes in the intestinal flora phylum level caused by chronic stress.

[0070] From the Circos diagram at the genus level, we can see that the top ten bacteria are: Muribaculaceae , Alloprevotella , Prevotellaceae_UCG-001 , Bacteroides , Lachnospiraceae_NK4A136_ group , Parabacteroides , Clostridia_UCG-014 , [Eubacterium]_fissicatena_group , Parasutterella , Alistipes .in, Muribaculaceae The proportion in the blank group was 59.9%, in the fish oil positive control group was 55.2%, in the tuna peptide group was 64.7%, and in the model group was 26.2%. The content in the model group was significantly decreased (P < 0.05). Bacteroides The proportion was 5.1% in the blank group, 2.38% in the fish oil positive control group, 2.27% in the tuna peptide group, and 13.94% in the model group. The content in the model group increased significantly (P < 0.05). Alistipes The proportion in the blank group was 0.7%, the positive control group in the fish oil group was 1.33%, the tuna peptide group was 0.78%, and the model group was 2.35%. The content in the model group increased significantly (P < 0.05). Muribaculaceae The abundance of Bacteroides , Alistipes The abundance of β-actinib and β-actinib can be increased and other bacterial flora can be restored to normal levels, thereby improving the intestinal flora disorder caused by chronic stress.

[0071] (V) Cluster heat map of correlation between 5-HT and behavior and genus-level microbiota

[0072] From the correlation cluster heat map between 5-HT, inflammatory factors, behavior, and intestinal flora, we can see that:

[0073] The 5-HT content in intestinal tissue was significantly positively correlated with the time spent in the central area of ​​the open field test and the time spent exploring the open arms of the Gaojia plus maze test (P < 0.05). Muribaculaceae The abundance of 5-HT was significantly negatively correlated with that of Alistipes (P<0.05), and was extremely significantly positively correlated with that of Alistipes (P<0.05). The results showed that the 5-HT content in the body was significantly correlated with the desire of mice to explore open spaces and high-altitude environments, and was also significantly correlated with the changes in the abundance of intestinal flora.

[0074] Serum LPS content and Bacteroides The levels of TNF-α, IL-1β and IL-6 were extremely significantly positively correlated with the 4-min immobility time after the tail suspension test (P < 0.05). The levels of IL-2 in serum were significantly negatively correlated with the time spent in the central area of ​​the open field test and the time spent exploring the open arms of the elevated plus maze test (P < 0.05), and were significantly positively correlated with the 4-min immobility time after the tail suspension test (P < 0.05). The results showed that the level of inflammation was closely related to depressive-like behavior.

[0075] At present, there are few studies on screening antidepressant active substances from marine food sources, and fish oil is widely used. Many studies have shown that ω-3 polyunsaturated fatty acids in fish oil can significantly improve systemic inflammation and depressive-like behavior in mice, but its efficacy needs to be improved. Tuna peptides, as a marine-derived peptide, have made certain progress in disease treatment and bioactivity research. However, there has been no report on the application of tuna peptides in the treatment of depression. This study found that after intervention with tuna peptides and fish oil, the 4-minute immobility time after the tail suspension test was reduced, the time to enter the middle area of ​​the open field test was increased, and the exploration time of the open arm in the elevated plus maze test was increased, which was significantly different from the model group, and its indicators basically returned to the level of the blank group. This shows that tuna peptides can significantly improve the depressive-like behavior of mice, and the intervention effect of tuna peptides on various indicators is significantly higher than that of the fish oil control group. Therefore, there is great potential for developing tuna peptides into antidepressant therapeutic agents. However, its mechanism of action needs to be explored to develop it into an applicable product.

[0076] Studies in recent years have shown that inflammation is closely related to depression. It is generally believed that inflammatory factors produced by peripheral inflammation will cross the blood-brain barrier into the brain, leading to apoptosis of neurons in the hippocampus and an abnormal decrease in 5-HT content, which in turn leads to the occurrence of depression, but there are still many mechanisms that have not been explored. Existing studies believe that TNF-α, IL-1β, and IL-6 are key inflammatory factors for the occurrence of depression. This study found that not only the levels of TNF-α, IL-1β, and IL-6 in the serum of mice in the model group increased significantly, but the IL-2 content also increased significantly. After intervention with tuna peptides, the above inflammatory indicators were significantly reduced and basically returned to the level of the blank control group. Among them, the reduction effect of IL-1β, IL-2, and IL-6 was significantly better than that of the fish oil control group. Correlation analysis showed that the IL-2 level was positively correlated with the changes in the tail suspension test indicators, and negatively correlated with the changes in the open field and elevated plus maze test indicators. This shows that IL-2 may also be an important inflammatory factor that causes depressive-like behavior in mice. Tuna peptides can significantly improve the inflammation of model mice, and its improvement effect is significantly better than fish oil.

[0077] 5-HT is a neurotransmitter that has important functions such as participating in brain mood regulation, intestinal motility, hormone secretion, and visceral sensation. It plays an important role in the pathogenesis of depression. Mainstream research believes that the abnormal decrease in 5-HT content in the hippocampus is the key to the occurrence of depression, but the specific mechanism is still unclear. Only 5% of the 5-HT in the body is synthesized in the central nervous system, and the remaining 95% comes from the gastrointestinal tract. 90% of 5-HT from the gastrointestinal tract is synthesized, secreted, and stored by enterochromaffin cells. Some studies believe that 5-HT in the peripheral body cannot directly pass through the blood-brain barrier, but some studies believe that peripheral 5-HT can affect the brain through the gut-brain axis, but the relationship between 5-HT in the periphery of the brain, especially in the intestine, and 5-HT in the hippocampus of the brain is not yet clear. This study found that the 5-HT levels in the hippocampus and intestinal tissues of the model group mice were significantly decreased; after tuna peptide intervention, the 5-HT levels of both returned to the level of the blank control group; correlation analysis results showed that the 5-HT content in the intestinal tissue was extremely significantly positively correlated with the open field test and the elevated plus maze test, indicating that there is a close correlation between the 5-HT content in the intestinal tissue and depressive-like behavior.

[0078] In addition, this study also found that the 5-HT content in the feces of the depressive-like behavior mouse model showed an opposite trend to the 5-HT content in the intestinal tissue and hippocampus, which has not been reported in the current literature. The reasons for the association and its role in the occurrence of depressive-like behavior remain to be explored. Studies have shown that intestinal flora is associated with the body's 5-HT concentration level. Jessica M. Yano et al. found that Lactobacillus brevis can affect the 5-HT content in feces and the number and function of enterochromaffin cells in intestinal tissue, thereby affecting the release of 5-HT. However, this study found that the 5-HT content in the feces of the model mice increased significantly. Muribaculaceae The abundance decreased significantly, and Alistipes The abundance of 5-HT in the intestinal flora increased significantly, and returned to the blank level after tuna peptide intervention. Therefore, the abnormal increase of 5-HT in the intestinal flora after chronic stress may be related to Muribaculaceae , Alistipes The above conclusion has not been reported.

[0079] Studies have shown that depression is closely related to intestinal flora disorders. Bacteroidota The abundance decreased significantly, while Firmicutes The abundance of tuna peptides increased significantly, and after intervention with tuna peptides, it returned to normal levels. The B / F ratio increased from 1.58 in the model group to 6.61 in the tuna peptide group, and basically returned to the level of 5.38 in the blank group. In Alpha diversity, the richness of the model group decreased, and after intervention with tuna peptides, the richness returned to the level of the blank group. This shows that tuna peptides can improve the disorder of intestinal flora structure caused by chronic stress. In addition, at the genus level, the model groupMuribaculaceae The abundance decreased significantly. Bacteroides , Alistipes The abundance of tuna peptides increased significantly, and after intervention, Muribaculaceae The abundance increased significantly. Bacteroides , Alistipes The abundance of tuna peptides decreased significantly, and there was no significant difference with the blank group. This indicates that the improvement of depressive behavior in mice by tuna peptides may be related to the regulation of the above key bacterial flora. Through correlation analysis, it was found that Muribaculaceae The abundance was significantly negatively correlated with the changes in inflammatory factor levels; Bacteroides and Alistipes The abundance of inflammatory factors was significantly positively correlated with the changes in inflammatory factor levels; and Bacteroides The abundance is significantly positively correlated with the content of LPS. Studies have shown that when the integrity of intestinal permeability is destroyed, LPS, a product of Gram-negative bacteria in the intestinal bacteria, can enter the blood and induce inflammation in the body. This study found that the LPS content in the serum of mice in the model group increased significantly, indicating that the intestinal barrier of mice would be damaged under long-term stress conditions, thereby inducing systemic inflammation; after tuna peptide intervention, the LPS content decreased significantly, indicating that tuna peptide may have the effect of regulating the intestinal barrier. It is generally believed that intestinal flora plays an important role in maintaining the stability of the intestinal barrier, and some of the flora play a key role. Weiwei Liang et al. found Muribaculaceae Changes in abundance are key bacterial groups that damage the intestinal barrier and induce inflammatory bowel disease. Yusook Chung et al. found that probiotics can regulate Muribaculaceae Although several studies have shown that Muribaculaceae The decreased abundance of Bacillus subtilis may be a key bacteria inducing intestinal barrier damage, but it has not been found in depression models. Bacteroides It is a Gram-negative bacterium. The LPS it secretes can enter the body when the intestinal barrier is damaged, inducing the release of inflammatory factors in the central nervous system and peripheral organs. Chronic stress can lead to Bacteroides Abundance increased. Alistipes It is a genus of the family Rikenbacteriaceae. Tiphaine Le Roy et al. reported that the intestinal flora under high-fat diet Alistipes The abundance of tuna peptides increased significantly, but there have been no reports on the association between this flora and intestinal barrier stability and depressive-like behavior. Therefore, the effect of tuna peptides on inflammation may be through increasing Muribaculaceae and reduce Bacteroid e and Alistipes This is achieved by protecting the intestinal barrier and reducing the entry of LPS into the blood.

[0080] In summary, tuna peptides may improve chronic stress-induced depressive-like behavior in mice by regulating intestinal flora, inflammation and intestinal 5-HT levels. The results can provide a theoretical basis for the development of tuna peptides as a new generation of green and safe antidepressant therapeutic agents.

[0081] The embodiments of the present invention are described in detail above, but the present invention is not limited to the described embodiments. For those skilled in the art, various changes, modifications, substitutions and variations of these embodiments are made without departing from the principles and spirit of the present invention, and still fall within the protection scope of the present invention.

Claims

1. Application of tuna peptide in the preparation of a therapeutic agent for improving chronic stress-induced depressive-like behavior in mice, It is characterized in that The preparation method of the tuna peptide is as follows: tuna meat homogenate is freeze-dried to form tuna powder, tuna powder and distilled water are mixed in a volume ratio of 1:5 for homogenization, pH is adjusted to 10.5, and an enzyme amount of 10000 U·g is added. -1 , enzymolysis in a 55°C constant temperature water bath for 8h, inactivate the enzyme in a 95°C water bath for 30min, cool to room temperature and centrifuge at 4000r / min for 20min, take the supernatant and perform vacuum freeze drying to obtain tuna peptide powder; the amount of tuna peptide used is 1.8g / (Kg m b d); The method for improving the depressive-like behavior induced by chronic stress in mice is selected from any one of the following: (1) The duration of despair is reduced, and / or; (2) increased desire to explore open spaces and aerial environments, and / or; (3) Behavioral manifestations return to normal.